Search for Terms or Answers
The RheumNow faculty reporters have been scouring and reporting on the best abstracts from the ACR. Here is a sampling of their choice abstract presentations reported during ACR 2020 Day 3 (#ACRbest).
The field of Rheumatology is an ever-nascent field with an incredible expansion in our therapeutic armamentarium over the past half century. An example of such advancement is easily appreciated when reflecting on the innovative treatment approach to Giant Cell Arteri
Another great way to get highlights from the ACR 2020 meeting - listen in for faculty reports and overviews.
Another great way to get highlights from the ACR 2020 meeting - listen in for faculty reports and overviews.
Another great way to get highlights from the ACR 2020 meeting - listen in for faculty reports and overviews.
Content covered includes:
The RheumNow faculty reporters have been scouring and reporting on the best abstracts from the ACR. Here is a sampling of their choice abstract presentations reported during ACR 2020 Day 2 (#ACRbest).
Another great way to get highlights from the ACR 2020 meeting - listen in to faculty reports and overviews.
Another great way to get highlights from the ACR 2020 meeting - listen in to faculty reports and overviews.
ACR20 convergence highlights a shift in gout management and uric acid lowering therapy (ULT). The new biologics pegdriticase and pegloticase are associated with risk of immunogenicity and loss of biological effects.
Another great way to get highlights from the ACR 2020 meeting - listen in to faculty reports and overviews.
Large vessel vasculitis (LVV) and CNS vasculitis are rare subsets of vasculitis. The challenges related to these diseases are well known to the rheumatologists who treat around the world.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
